Mass spectrometry of intact complexes of benzyl styryl sulfone ON1910Na with albumin using direct serum injection
John Roboz(Temple University), James F. Holland(Mayo Clinic), Jian‐Dong Jiang(Ningbo University), Stanley C. Bell(Onconova Therapeutics (United States)), Yanling Wang(Nanjing Medical University), Takao Ohnuma(Temple University), Premkumar Reddy(Onconova Therapeutics (United States)), Sool Yeon Cho(Onconova Therapeutics (United States))
Cancer Research
April 15, 2006
Cited by 0
Related Papers
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Filtration Leukapheresis for Granulocyte Transfusion Therapy
|New England Journal of Medicine|1975|255
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
|Theranostics|2019|185
Loss of Epigenetic Control of <i>Synuclein-γ</i> Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers
|Cancer Research|2005|179
Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine
|Arteriosclerosis Thrombosis and Vascular Biology|2005|171